←Back to Expert Scholars
Translational Medicine / 转化医学RCC, Non Clear Cell
Chung-Han Lee
MD, PhD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Medical Oncologist
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Chung-Han Lee leads trials in non clear cell RCC at Memorial Sloan Kettering and established lenvatinib plus everolimus activity in this setting. His research focuses on papillary, chromophobe, and translocation RCC. He has helped define novel targeted and immunotherapy combinations for rare RCC histologies.
Share:
🧪Research Fields 研究领域
non clear cell RCC
lenvatinib
cabozantinib
clinical trials
GU oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Chung-Han Lee 的研究动态
Follow Chung-Han Lee's research updates
留下邮箱，当我们发布与 Chung-Han Lee（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment